Chapter/Section Purchase

1 Study Coverage
1.1 Remicade (infliximab) Drug Product Introduction
1.2 Market by Type
1.2.1 Global Remicade (infliximab) Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Brands Drugs
1.2.3 Generic Drugs
1.3 Market by Application
1.3.1 Global Remicade (infliximab) Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Crohn's Disease
1.3.3 Pediatric Crohn's Disease
1.3.4 Ulcerative Colitis
1.3.5 Pediatric Ulcerative Colitis
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Remicade (infliximab) Drug Sales Estimates and Forecasts 2017-2028
2.2 Global Remicade (infliximab) Drug Revenue Estimates and Forecasts 2017-2028
2.3 Global Remicade (infliximab) Drug Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Remicade (infliximab) Drug Sales by Region
2.4.1 Global Remicade (infliximab) Drug Sales by Region (2017-2022)
2.4.2 Global Sales Remicade (infliximab) Drug by Region (2023-2028)
2.5 Global Remicade (infliximab) Drug Revenue by Region
2.5.1 Global Remicade (infliximab) Drug Revenue by Region (2017-2022)
2.5.2 Global Remicade (infliximab) Drug Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Remicade (infliximab) Drug Sales by Manufacturers
3.1.1 Global Top Remicade (infliximab) Drug Manufacturers by Sales (2017-2022)
3.1.2 Global Remicade (infliximab) Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Remicade (infliximab) Drug in 2021
3.2 Global Remicade (infliximab) Drug Revenue by Manufacturers
3.2.1 Global Remicade (infliximab) Drug Revenue by Manufacturers (2017-2022)
3.2.2 Global Remicade (infliximab) Drug Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Remicade (infliximab) Drug Revenue in 2021
3.3 Global Remicade (infliximab) Drug Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Remicade (infliximab) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Remicade (infliximab) Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Remicade (infliximab) Drug Sales by Type
4.1.1 Global Remicade (infliximab) Drug Historical Sales by Type (2017-2022)
4.1.2 Global Remicade (infliximab) Drug Forecasted Sales by Type (2023-2028)
4.1.3 Global Remicade (infliximab) Drug Sales Market Share by Type (2017-2028)
4.2 Global Remicade (infliximab) Drug Revenue by Type
4.2.1 Global Remicade (infliximab) Drug Historical Revenue by Type (2017-2022)
4.2.2 Global Remicade (infliximab) Drug Forecasted Revenue by Type (2023-2028)
4.2.3 Global Remicade (infliximab) Drug Revenue Market Share by Type (2017-2028)
4.3 Global Remicade (infliximab) Drug Price by Type
4.3.1 Global Remicade (infliximab) Drug Price by Type (2017-2022)
4.3.2 Global Remicade (infliximab) Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Remicade (infliximab) Drug Sales by Application
5.1.1 Global Remicade (infliximab) Drug Historical Sales by Application (2017-2022)
5.1.2 Global Remicade (infliximab) Drug Forecasted Sales by Application (2023-2028)
5.1.3 Global Remicade (infliximab) Drug Sales Market Share by Application (2017-2028)
5.2 Global Remicade (infliximab) Drug Revenue by Application
5.2.1 Global Remicade (infliximab) Drug Historical Revenue by Application (2017-2022)
5.2.2 Global Remicade (infliximab) Drug Forecasted Revenue by Application (2023-2028)
5.2.3 Global Remicade (infliximab) Drug Revenue Market Share by Application (2017-2028)
5.3 Global Remicade (infliximab) Drug Price by Application
5.3.1 Global Remicade (infliximab) Drug Price by Application (2017-2022)
5.3.2 Global Remicade (infliximab) Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America Remicade (infliximab) Drug Market Size by Type
6.1.1 North America Remicade (infliximab) Drug Sales by Type (2017-2028)
6.1.2 North America Remicade (infliximab) Drug Revenue by Type (2017-2028)
6.2 North America Remicade (infliximab) Drug Market Size by Application
6.2.1 North America Remicade (infliximab) Drug Sales by Application (2017-2028)
6.2.2 North America Remicade (infliximab) Drug Revenue by Application (2017-2028)
6.3 North America Remicade (infliximab) Drug Market Size by Country
6.3.1 North America Remicade (infliximab) Drug Sales by Country (2017-2028)
6.3.2 North America Remicade (infliximab) Drug Revenue by Country (2017-2028)
6.3.3 the United States
6.3.4 Canada
7 Europe
7.1 Europe Remicade (infliximab) Drug Market Size by Type
7.1.1 Europe Remicade (infliximab) Drug Sales by Type (2017-2028)
7.1.2 Europe Remicade (infliximab) Drug Revenue by Type (2017-2028)
7.2 Europe Remicade (infliximab) Drug Market Size by Application
7.2.1 Europe Remicade (infliximab) Drug Sales by Application (2017-2028)
7.2.2 Europe Remicade (infliximab) Drug Revenue by Application (2017-2028)
7.3 Europe Remicade (infliximab) Drug Market Size by Country
7.3.1 Europe Remicade (infliximab) Drug Sales by Country (2017-2028)
7.3.2 Europe Remicade (infliximab) Drug Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 UK
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Remicade (infliximab) Drug Market Size by Type
8.1.1 Asia Pacific Remicade (infliximab) Drug Sales by Type (2017-2028)
8.1.2 Asia Pacific Remicade (infliximab) Drug Revenue by Type (2017-2028)
8.2 Asia Pacific Remicade (infliximab) Drug Market Size by Application
8.2.1 Asia Pacific Remicade (infliximab) Drug Sales by Application (2017-2028)
8.2.2 Asia Pacific Remicade (infliximab) Drug Revenue by Application (2017-2028)
8.3 Asia Pacific Remicade (infliximab) Drug Market Size by Region
8.3.1 Asia Pacific Remicade (infliximab) Drug Sales by Region (2017-2028)
8.3.2 Asia Pacific Remicade (infliximab) Drug Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Remicade (infliximab) Drug Market Size by Type
9.1.1 Latin America Remicade (infliximab) Drug Sales by Type (2017-2028)
9.1.2 Latin America Remicade (infliximab) Drug Revenue by Type (2017-2028)
9.2 Latin America Remicade (infliximab) Drug Market Size by Application
9.2.1 Latin America Remicade (infliximab) Drug Sales by Application (2017-2028)
9.2.2 Latin America Remicade (infliximab) Drug Revenue by Application (2017-2028)
9.3 Latin America Remicade (infliximab) Drug Market Size by Country
9.3.1 Latin America Remicade (infliximab) Drug Sales by Country (2017-2028)
9.3.2 Latin America Remicade (infliximab) Drug Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Remicade (infliximab) Drug Market Size by Type
10.1.1 Middle East and Africa Remicade (infliximab) Drug Sales by Type (2017-2028)
10.1.2 Middle East and Africa Remicade (infliximab) Drug Revenue by Type (2017-2028)
10.2 Middle East and Africa Remicade (infliximab) Drug Market Size by Application
10.2.1 Middle East and Africa Remicade (infliximab) Drug Sales by Application (2017-2028)
10.2.2 Middle East and Africa Remicade (infliximab) Drug Revenue by Application (2017-2028)
10.3 Middle East and Africa Remicade (infliximab) Drug Market Size by Country
10.3.1 Middle East and Africa Remicade (infliximab) Drug Sales by Country (2017-2028)
10.3.2 Middle East and Africa Remicade (infliximab) Drug Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Janssen
11.1.1 Janssen Corporation Information
11.1.2 Janssen Overview
11.1.3 Janssen Remicade (infliximab) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Janssen Remicade (infliximab) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Janssen Recent Developments
11.2 Hospira
11.2.1 Hospira Corporation Information
11.2.2 Hospira Overview
11.2.3 Hospira Remicade (infliximab) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Hospira Remicade (infliximab) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Hospira Recent Developments
11.3 Celltrion Healthcare
11.3.1 Celltrion Healthcare Corporation Information
11.3.2 Celltrion Healthcare Overview
11.3.3 Celltrion Healthcare Remicade (infliximab) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Celltrion Healthcare Remicade (infliximab) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Celltrion Healthcare Recent Developments
11.4 Epirus Biopharmaceuticals
11.4.1 Epirus Biopharmaceuticals Corporation Information
11.4.2 Epirus Biopharmaceuticals Overview
11.4.3 Epirus Biopharmaceuticals Remicade (infliximab) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Epirus Biopharmaceuticals Remicade (infliximab) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Epirus Biopharmaceuticals Recent Developments
11.5 Samsung Bioepsis
11.5.1 Samsung Bioepsis Corporation Information
11.5.2 Samsung Bioepsis Overview
11.5.3 Samsung Bioepsis Remicade (infliximab) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Samsung Bioepsis Remicade (infliximab) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Samsung Bioepsis Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Remicade (infliximab) Drug Industry Chain Analysis
12.2 Remicade (infliximab) Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Remicade (infliximab) Drug Production Mode & Process
12.4 Remicade (infliximab) Drug Sales and Marketing
12.4.1 Remicade (infliximab) Drug Sales Channels
12.4.2 Remicade (infliximab) Drug Distributors
12.5 Remicade (infliximab) Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Remicade (infliximab) Drug Industry Trends
13.2 Remicade (infliximab) Drug Market Drivers
13.3 Remicade (infliximab) Drug Market Challenges
13.4 Remicade (infliximab) Drug Market Restraints
14 Key Findings in The Global Remicade (infliximab) Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer